Le Lézard
Classified in: Health
Subject: ATY

ALEXION INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alexion Pharmaceuticals, Inc. - (ALXN)



NEW ORLEANS, Oct. 6, 2017 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN).

Kahn Swick & Foti, LLC ("KSF") - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto/Kahn Swick & Foti, LLC)

Since late 2016, the Company has been the subject of investigations by numerous legal and regulatory authorities and significant litigation relating to its use of a myriad of unethical and possibly illegal sales and promotion campaigns by its salespeople in connection with its flagship drug, Soliris.

The actions of the Company, as directed by its executives, have exposed it to significant financial losses, an exodus of high-level executives, investigations by the U.S. Securities and Exchange Commission, the U.S. Department of Justice, the U.S. Attorney's Office for the District of Massachusetts, the U.S. Department of Health and Human Services and Brazilian law enforcement officials.  Further, the Company has been sued in an ongoing securities class action lawsuit for failing to disclose material information and has also received a formal demand for inspection of its books and records made by a shareholder.  Recently, a shareholder derivative lawsuit was filed against the Company's current and former executives. 

KSF's investigation is focusing on whether Alexion's officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Alexion shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447

 

SOURCE Kahn Swick & Foti, LLC


These press releases may also interest you

at 12:30
DUBLIN, October 18, 2017 /PRNewswire/ -- The "Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021" report has been added to Research and Markets' offering. The global circulating tumor cell (CTC) diagnostics market to grow at a CAGR...

at 12:30
HOUSTON, Oct. 18, 2017 /PRNewswire-USNewswire/ -- The college football season is heating up and this year's American Heart Association (AHA) Paul "Bear" Bryant Awards Watch List includes a who's who lineup of new faces and old favorites. Representing...

at 12:29
STOCKHOLM, October 18, 2017 /PRNewswire/ -- Today at the United Nations headquarters in New York, Essity, a leading global hygiene and health company, convened the fifth annual UN Foundation Dialogue on the Global Agenda. The Dialogue brought...

at 12:24
SAN RAFAEL, Calif., Oct. 18, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) updated the investment community on the Company's development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases....

at 12:00
DUBLIN, October 18, 2017 /PRNewswire/ -- The "Global Point-of-Care Testing Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering. Global point-of-care...

at 12:00
TIANJIN, China, Oct. 18, 2017 /PRNewswire/ -- Asymchem Laboratories (Tianjin) Co., Ltd. (SHE: 002821, "Asymchem") today announced that its API facility, Jilin Asymchem Laboratories Co., Ltd. in P.R. China, ("Dunhua"), has successfully passed an...




News published on 6 october 2017 at 22:50 and distributed by: